Levodopa/Carbidopa/Entacapona Kern Pharma (Carbidopa, Entacapone, Levodopa)

The combination works on three levels: levodopa is converted to dopamine in the brain, carbidopa blocks peripheral conversion of levodopa so more reaches the central nervous system, and entacapone inhibits the COMT enzyme, slowing levodopa breakdown and extending its therapeutic effect.

Dosage is individualized and determined by the prescribing clinician based on disease severity, response, and tolerability. The prescriber will adjust the amount and frequency to achieve optimal symptom control while minimizing side effects.

Safety data are limited. The medication should only be used during pregnancy or lactation if the potential benefits to the mother outweigh any possible risk to the fetus or infant. Consultation with a healthcare professional is essential before initiating therapy in these situations.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Standard levodopa alone is rapidly metabolized, leading to fluctuating plasma levels and motor “off” periods. Adding carbidopa and entacapone reduces peripheral metabolism and prolongs levodopa’s half‑life, resulting in smoother symptom control, fewer dose escalations, and potentially reduced dyskinesia compared with levodopa monotherapy.

Store the tablets at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in humid or excessively hot environments.

The medication is taken orally, usually with a glass of water. It can be taken with or without food, but a consistent routine regarding meals helps maintain stable drug absorption. Patients should follow the prescribing clinician’s instructions regarding timing and any dose adjustments.

Serious risks include dyskinesia (involuntary movements), severe hypotension, hallucinations or psychosis, neuroleptic malignant syndrome, cardiac arrhythmias, and rare cases of severe liver injury. Patients should be monitored regularly for these events, and any concerning symptoms should prompt immediate medical evaluation.

The drug is contraindicated in patients with known hypersensitivity to levodopa, carbidopa, entacapone, or any excipients. It should also be avoided in individuals taking non‑selective MAO inhibitors or those with a history of malignant neuroleptic syndrome. Caution is advised for patients with severe cardiovascular disease, hepatic impairment, or narrow‑angle glaucoma.